chemical materials

Home - Products - chemical materials

Avanafil

  • Product Name: Avanafil
  • CasNo: 330784-47-9
  • Purity:
  • Appearance: White solid

Mobile/Wechat/WhatsApp: +852 61915425

Email:niki@healthtide-api.com

Inquiry

CasNo: 330784-47-9

Molecular Formula: C23H26ClN7O3

Appearance: White solid

Quality Factory Supply 330784-47-9 Avanafil with Safe Delivery / Shipping

  • Molecular Formula:C23H26ClN7O3
  • Molecular Weight:483.958
  • Appearance/Colour:White solid 
  • Melting Point:150-152 °C 
  • Refractive Index:1.651 
  • PKA:11.84±0.46(Predicted) 
  • PSA:125.39000 
  • Density:1.373 g/cm3 
  • LogP:2.96070 

Avanafil (Cas 330784-47-9) Usage

Description Avanafil is a medication belonging to the class of phosphodiesterase (PDE) inhibitors, specifically PDE5 inhibitors. It is primarily used for the treatment of erectile dysfunction (ED), a condition characterized by the inability to achieve or maintain an erection sufficient for sexual activity. Avanafil works by increasing blood flow to the penis during sexual stimulation, which facilitates the attainment and maintenance of an erection. The medication is available in various dose strengths, including 50 mg, 100 mg, and 200 mg, and is typically taken as needed to achieve an erection. It is recommended to use the lowest effective dose to minimize the risk of adverse effects. Avanafil has a rapid onset of action, with a median time to maximum concentration (Tmax) of 30 to 45 minutes and a duration of action of approximately 5 hours.

Uses

As a highly selective PDE5 inhibitor, avanafil competitively antagonizes cyclic guanosine monophosphate, leading to vasodilation of penile blood vessels and enhanced erectile function. Unlike some other PDE inhibitors, avanafil exhibits a high ratio of inhibiting PDE5 compared to other PDE subtypes, allowing for effective treatment of ED while minimizing adverse effects. Avanafil was approved by the US Food and Drug Administration (FDA) for the treatment of erectile dysfunction on April 27, 2012, and subsequently by the European Medicines Agency (EMA) on June 21, 2013. It is marketed under the brand names Stendra and Spedra.

HEALTHTIDE BIOTECH CO.,LTD. is a collection of production and sales of biotechnology companies. Our company mainly sells plant extracts, chemical raw materials,food additives,raw material of cosmetics. Our company has overseas warehouses in Vancouver and Toronto in Canada, Germany and the Netherlands in Europe, Melbourne and Sydney in Australia, and Mocheng in Mexico.

Leave Your Message

Relevant Products